Coherus Oncology Inc. (CHRS) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Coherus Oncology Inc.

    NASDAQ: CHRS · Real-Time Price · USD
    1.50
    0.05 (3.45%)
    At close: Sep 26, 2025, 3:59 PM
    1.49
    -0.67%
    After-hours: Sep 26, 2025, 06:58 PM EDT

    Coherus Oncology Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 28.51M -237.89M -291.75M -287.1M
    Depreciation & Amortization
    		 5.28M 3.79M 3.7M 3.45M
    Stock-Based Compensation
    		 27.8M 43.11M 50.74M 51.36M
    Other Working Capital
    		 -57.57M 136.83M -40.41M 13.68M
    Other Non-Cash Items
    		 -137.92M 52.93M 75.45M 143.05M
    Deferred Income Tax
    		 n/a n/a n/a 9.44M
    Change in Working Capital
    		 55.89M -36.83M -79.26M 42.36M
    Operating Cash Flow
    		 -20.44M -174.88M -241.12M -37.43M
    Capital Expenditures
    		 n/a -286K -2.04M -1.29M
    Cash Acquisitions
    		 n/a 845K n/a 1.29M
    Purchase of Investments
    		 n/a -19.51M -127.38M -182.49M
    Sales Maturities Of Investments
    		 14.89M 157.64M n/a 181.36M
    Other Investing Acitivies
    		 215.43M 5.95M -37.43M -137.29M
    Investing Cash Flow
    		 230.32M 144.64M -166.85M -138.41M
    Debt Repayment
    		 -223.41M n/a 49.93M -672K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 34.98M -2.12M -1.96M 54.3M
    Financial Cash Flow
    		 -186.97M 69.6M 54.33M 51.88M
    Net Cash Flow
    		 22.91M 39.36M -353.65M -123.96M
    Free Cash Flow
    		 -20.44M -175.17M -243.16M -38.72M

    Add to Watchlist